EchoSolv™ gives physicians access to an easy-to-use dashboard, customizable alerts, and a deeper view of risk probability to support the accurate identification of risk in patients who might benefit from therapeutic intervention or more proactive vigilance.
EchoSolv™

Designed for cardiologists

Developed by Echo IQ’s team of leading practitioners and technologists, EchoSolv™ provides an AI-powered risk assessment of structural heart disease aimed at identifying at-risk patients who may benefit for further referral and reduce the risk of misdiagnosis.

Heart disease menu available today:

Publications 1

4

Clinical Studies

4

Countries 2

3
EchoSolv™ gives physicians access to an easy-to-use dashboard, customizable alerts, and a deeper view of risk probability to support the accurate identification of risk in patients who might benefit from therapeutic intervention or more proactive vigilance.
EchoSolv™

Designed for cardiologists

Developed by Echo IQ’s team of leading practitioners and
technologists, EchoSolv™ provides an AI-powered risk assessment of structural heart disease aimed at identifying at-risk patients who may benefit for further referral and reduce the risk of misdiagnosis.

Heart disease menu available today:

Countries 2

4

Clinical Studies

4

Countries 2

3

1 Peer-reviewed publications on the EchoSolv™ technology.

2 EchoSolv™ is currently available in the US and Australia as a guideline-led decision-support tool. Full phenotyping capabilities will be available in these geographies pending FDA approval. Full capabilities are currently available in New Zealand.

Guided by practising cardiologists, this proprietary platform is deeply rooted in the latest in medical science and AI. EchoSolv™ helps ensure severe patients are flagged, so your cardiac care team can prioritize efficiently and confidently.

Augmented by additional checks and validated in clinical studies, EchoSolv™ is as comprehensive as it is easy to integrate into your practice.

Comprehensive

Improved patient outcomes

EchoSolv™ is designed to answer the toughest questions a case may pose. Leveraging every computational power and methodology available, EchoSolv™ takes every calculation possible in under 3 seconds. As a decision-support tool, EchoSolv works like a sonographer who has been trained on over 650,000 patient cases, rigorously studying every structure and haemodynamic process in the heart to better understand the complex nuances in detecting certain diseases.

Unbiased

Deep learning, simple to use

This decision-support tool reduces the effect of human cognitive load to make consistent, accurate evaluations easier. Whether you want to prioritize severe cases or review all your sites for planning, EchoSolv™ makes it easy to find the most at-risk patients.

100% of in-guideline patients identified.